144 related articles for article (PubMed ID: 10481582)
1. [Binding of the antileukemia drug Escherichia coli L-asparaginase to the plasma membrane of normal human mononuclear cells].
Mercado-Vianco L; Arenas-Díaz G
Sangre (Barc); 1999 Jun; 44(3):204-9. PubMed ID: 10481582
[TBL] [Abstract][Full Text] [Related]
2. [Escherichia coli L-asparaginase induces phosphorylation of endogenous polypeptides in human immune cells].
Mercado L; Arenas G
Sangre (Barc); 1999 Dec; 44(6):438-42. PubMed ID: 10822757
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
Park YK; Abuchowski A; Davis S; Davis F
Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
[TBL] [Abstract][Full Text] [Related]
4. Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
Mehta RK; Verma S; Pati R; Sengupta M; Khatua B; Jena RK; Sethy S; Kar SK; Mandal C; Roehm KH; Sonawane A
J Biol Chem; 2014 Feb; 289(6):3555-70. PubMed ID: 24297177
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides.
Uren JR; Ragin RC
Cancer Res; 1979 Jun; 39(6 Pt 1):1927-33. PubMed ID: 376113
[TBL] [Abstract][Full Text] [Related]
6. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
[TBL] [Abstract][Full Text] [Related]
7. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
Qian G; Zhou J; Ma J; Wang D; He B
Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
[TBL] [Abstract][Full Text] [Related]
8. Binding of asparaginase to mouse monocytes.
Mori I; Hayashi T; Kitazima S; Yamamoto H
Int J Exp Pathol; 1992 Oct; 73(5):585-92. PubMed ID: 1419776
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of L-asparaginase from Cylindrocarpon obtusisporum MB-10 and its effect on the immune system.
Raha SK; Dey SK; Roy SK; Chaudhuri S; Chakrabarty SL
Biochem Int; 1990 Sep; 21(6):1001-11. PubMed ID: 2080916
[TBL] [Abstract][Full Text] [Related]
10. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers.
Hu J; Bok D
Mol Vis; 2001 Feb; 7():14-9. PubMed ID: 11182021
[TBL] [Abstract][Full Text] [Related]
11. [Cross-immunogenicity of various bacterial L-asparaginases].
D'iakov IN; Pokrovskiĭ VS; Sannikova EP; Bulushova NV; Pokrovskaia MV; Aleksandrova SS
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):100-4. PubMed ID: 25816523
[TBL] [Abstract][Full Text] [Related]
12. L-aspartate aminotransferase and L-asparaginase in rat lymph node: a histoenzymological and immunohistochemical study.
Gragera RR; de Miguel E; Muñiz E; Arenas-Díaz G; Alonso MJ; Gómez de Segura IA; Martínez-Rodríguez R
Eur J Histochem; 1995; 39(3):195-200. PubMed ID: 8630437
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.
Ran S; He J; Huang X; Soares M; Scothorn D; Thorpe PE
Clin Cancer Res; 2005 Feb; 11(4):1551-62. PubMed ID: 15746060
[TBL] [Abstract][Full Text] [Related]
15. [Effect of different pH values on the activity and quaternary structure of asparaginase in Escherichia coli extracts].
Maksimov VI; Molodova GA; Bespalova TI; Denisov VM
Prikl Biokhim Mikrobiol; 1975; 11(4):539-45. PubMed ID: 1737
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine micro-region of E. coli L-asparaginase.
Zhongxiao H; Shijun Q; Fengxi H
Sci Sin; 1981 Sep; 24(9):1285-91. PubMed ID: 7029710
[TBL] [Abstract][Full Text] [Related]
17. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
McWhirter JR; Kretz-Rommel A; Saven A; Maruyama T; Potter KN; Mockridge CI; Ravey EP; Qin F; Bowdish KS
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1041-6. PubMed ID: 16418292
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
[TBL] [Abstract][Full Text] [Related]
19. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
20. [Antibody sandwich enzyme-linked immunoadsorbent assay for determination of recombinant E. coli L-asparaginase in rat plasma and its pharmacokinetics].
Chen JH; Wu WT; Kazuyuki H
Yao Xue Xue Bao; 2003 Aug; 38(8):613-6. PubMed ID: 14628454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
